|
98
|
275
|
5gwaA |
Crystal structure of tla-3 extended-spectrum beta-lactamase in a complex with avibactam |
|
97
|
261
|
6c7aA |
Conformational changes in a class a beta lactamase that prime it for catalysis |
|
92
|
260
|
6c79A |
Conformational changes in a class a beta lactamase that prime it for catalysis |
|
92
|
259
|
6c78A |
Substrate binding induces conformational changes in a class a beta lactamase that primes it for catalysis |
|
98
|
263
|
6bt6A |
Ctx-m-14 s237a beta-lactamase in complex with a non-covalent tetrazole inhibitor |
|
92
|
268
|
6b1hA |
Crystal structure kpc-2 beta-lactamase complexed with wck 4234 by co-crystallization |
|
92
|
268
|
6b1xA |
Crystal structure kpc-2 beta-lactamase complexed with wck 5153 by soaking |
|
98
|
263
|
6aykA |
Crystal structure of tem1 beta-lactamase mutant i263a in the presence of 1.2 mpa xenon |
|
88
|
265
|
6b6eA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 500ms |
|
92
|
268
|
6b1jA |
Crystal structure kpc-2 beta-lactamase complexed with wck 5107 by soaking |
|
81
|
265
|
6b6fA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 2sec |
|
90
|
265
|
6b6bA |
Beta-lactamase, unmixed needles crystal form |
|
92
|
268
|
6b1fA |
Crystal structure kpc-2 beta-lactamase complexed with wck 4234 by soaking |
|
85
|
265
|
6b6dA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 100ms |
|
94
|
268
|
6b1wA |
Crystal structure kpc-2 beta-lactamase complexed with wck 5107 by co-crystallization |
|
88
|
265
|
6b6cA |
Beta-lactamase, mixed with ceftriaxone, needles crystal form, 30ms |
|
87
|
265
|
6b6aA |
Beta-lactamase, 2secs timepoint, mixed, shards crystal form |
|
90
|
265
|
6b5yA |
Beta-lactamase, mixed with ceftriaxone, 30ms time point, shards crystal form |
|
88
|
265
|
6b68A |
Beta-lactamase, 100ms timepoint, mixed, shards crystal form |
|
89
|
265
|
6b69A |
Beta-lactamase, 500ms timepoint, mixed, shards crystal form |
|
81
|
263
|
6b2nA |
Crystal structure of tem-1 beta-lactamase mutant m182n |
|
95
|
268
|
6b1yA |
Crystal structure kpc-2 beta-lactamase complexed with wck 5153 by co-crystallization |
|
91
|
265
|
6b5xA |
Beta-lactamase, unmixed shards crystal form |
|
93
|
263
|
6apaA |
Crystal structure of tem1 beta-lactamase mutant i263a |
|
105
|
277
|
5vpqA |
Crystal structure of beta-lactamase from burkholderia phymatum |
|
92
|
260
|
5a92A |
15k x-ray structure with cefotaxime: exploring the mechanism of beta- lactam ring protonation in the class a beta-lactamase acylation mechanism using neutron and x-ray crystallography |
|
91
|
260
|
5a90A |
100k neutron ligand free: exploring the mechanism of beta-lactam ring protonation in the class a beta-lactamase acylation mechanism using neutron and x-ray crystallography |
|
95
|
260
|
5a93A |
293k joint x-ray neutron with cefotaxime: exploring the mechanism of beta-lactam ring protonation in the class a beta-lactamase acylation mechanism using neutron and x-ray crystallography |
|
95
|
263
|
4pm5A |
Crystal structure of ctx-m-14 s70g beta-lactamase in complex with cefotaxime at 1.26 angstroms resolution |
|
99
|
270
|
4ev4A |
Crystal structure of serratia fonticola carbapenemase sfc-1 e166a mutant with the acylenzyme intermediate of meropenem |
|
99
|
270
|
4euzA |
Crystal structure of serratia fonticola carbapenemase sfc-1 s70a-meropenem complex |
|
84
|
268
|
4ewfA |
The crystal structure of beta-lactamase from sphaerobacter thermophilus dsm 20745 |
|
89
|
265
|
4q8iA |
Crystal structure of beta-lactamase from m.tuberculosis covalently complexed with tebipenem |
|
80
|
265
|
4eblA |
Blac e166a faropenem acyl-intermediate complex |
|
80
|
265
|
4ebpA |
Blac e166a cefotaxime acyl-intermediate complex |
|
79
|
265
|
4ebnA |
Blac amoxicillin acyl-intermediate complex |
|
101
|
271
|
4eqiA |
Crystal structure of serratia fonticola carbapenemase sfc-1 |
|
202
|
637
|
4dxcA |
Crystal structure of the engineered mbp tem-1 fusion protein rg13, c2 space group |
|
208
|
637
|
4dxbA |
2.29a structure of the engineered mbp tem-1 fusion protein rg13 in complex with zinc, p1 space group |
|
94
|
263
|
4de0A |
Ctx-m-9 class a beta-lactamase complexed with compound 16 |
|
95
|
260
|
4ddsA |
Ctx-m-9 class a beta-lactamase complexed with compound 11 |
|
95
|
260
|
4de3A |
Ctx-m-9 class a beta-lactamase complexed with compound 4 |
|
90
|
280
|
4d2oA |
Crystal structure of the class a extended-spectrum beta-lactamase per- 2 |
|
93
|
263
|
4de1A |
Ctx-m-9 class a beta-lactamase complexed with compound 18 |
|
90
|
260
|
4de2A |
Ctx-m-9 class a beta-lactamase complexed with compound 12 |
|
91
|
265
|
4df6A |
Crystal structure of the inhibitor nxl104 covalent adduct with tb b-lactamase |
|
97
|
260
|
4ddyA |
Ctx-m-9 class a beta-lactamase complexed with compound 10 |
|
88
|
261
|
4c3qA |
Neutron structure of a perdeuterated toho-1 r274n r276n double mutant beta-lactamase in complex with a fully deuterated boronic acid (bzb) at 100k |
|
88
|
261
|
4bd0A |
X-ray structure of a perdeuterated toho-1 r274n r276n double mutant beta-lactamase in complex with a fully deuterated boronic acid (bzb) |
|
94
|
261
|
4bd1A |
Neutron structure of a perdeuterated toho-1 r274n r276n double mutant beta-lactamase in complex with a fully deuterated boronic acid (bzb) |
